Santa Clara (California) [US], September 14 (ANI/PRNewswire): Advanced software tools continue to play a major role in 4,500+ rare disease drugs innovation and development, helping overcome challenges such as limited availability of patients and high-risk costs. To ensure successful remedies
Geneva [Switzerland], September 10 (ANI/PRNewswire): An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon.
Washington [US], September 4 (ANI): A small device that detects food craving-related brain activity in a key brain region, and responds by electrically stimulating that region, has shown promise in a pilot clinical trial in two patients with loss-of-control binge eating disorder (BED), accor
Hyderabad (Telangana) [India] September 1 (ANI): Hyderabad-based vaccines manufacturer Biological E Limited announced on Thursday that the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) reviewed and approved the Phase III infants clinical trial data
Maryland [US], August 30 (ANI): According to a recent study published in the Annals of Internal Medicine, the amount of SARS-CoV-2 antigen detected in the blood of patients hospitalized with COVID-19 is related to the severity of the illness and other clinical outcomes.
Washington [US], August 30 (ANI): A small device that detects food craving-related brain activity in a key brain region, and responds by electrically stimulating that region, has shown promise in a pilot clinical trial in two patients with loss-of-control binge eating disorder (BED), accordi
Geneva [Switzerland], August 24 (ANI/PRNewswire): The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approv
Washington [US], August 23 (ANI): Children who suffer a relapse of aggressive cancer known as neuroblastoma have small chances of survival. However, researchers have now shown that DHODH blockers, which are well-tolerated in humans, can cure neuroblastoma in mice if administered in combinati
Dallas (Texas) [US], August 21 (ANI): There are many different types of kidney cancer, and they can manifest with a few small metastases or many large ones. Today, though, every patient receives the same care. All of them are given medication.
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Geneva [Switzerland], August 10 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial
Atlanta (Georgia) [US], August 10 (ANI/PRNewswire): Frontier Biotechnologies, a biopharmaceutical company focused on the discovery, development and dissemination of innovative medicines that improve patient health, announced positive results from the Phase 1 clinical trial of its drug candid